Mor George Adi

Insider profile

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Mor George Adi's trades of Chemomab Therapeutics Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-01-05 2023-01-03 PlS Planned sale
68,670 +4.4%
499.06
US$911,302
68,670 +4.4% 499.06 US$911,302
2023-01-05 2023-01-03 PlS Planned sale
85,419 -20.5%
254.79
US$3,691,179
85,419 -20.5% 254.79 US$3,691,179
2022-11-17 2022-11-16 S Sale
23,211 -9.5%
293.16
US$918,810
23,211 -9.5% 293.16 US$918,810
2022-11-17 2022-11-16 S Sale
324,775 -50.0%
2.08
US$677,091
324,775 -50.0% 2.08 US$677,091